Vicapsys Life Sciences, Inc. (VICP)
0.65
+0.14
(+27.45%)
USD |
OTCM |
Oct 02, 16:00
Vicapsys Life Sciences Net Income (Quarterly) : -0.1046M for March 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.1046M |
| March 31, 2025 | -0.1814M |
| December 31, 2024 | -0.2371M |
| September 30, 2024 | -0.2355M |
| June 30, 2024 | -0.1901M |
| March 31, 2024 | -0.3271M |
| December 31, 2023 | -0.5948M |
| September 30, 2023 | -0.2403M |
| June 30, 2023 | -0.1357M |
| March 31, 2023 | -0.2113M |
| December 31, 2022 | -0.4926M |
| September 30, 2022 | -0.1451M |
| June 30, 2022 | -0.1801M |
| March 31, 2022 | -0.167M |
| Date | Value |
|---|---|
| December 31, 2021 | -0.1039M |
| September 30, 2021 | -0.1112M |
| June 30, 2021 | -0.0721M |
| March 31, 2021 | 0.0502M |
| December 31, 2020 | -0.0805M |
| September 30, 2020 | -0.0892M |
| June 30, 2020 | -0.2316M |
| March 31, 2020 | -0.3645M |
| December 31, 2019 | -0.2496M |
| June 30, 2019 | -0.1513M |
| December 31, 2018 | -1.001M |
| March 31, 2010 | -0.6623M |
| March 31, 2009 | -0.3169M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.1046M |
| EPS Diluted (Quarterly) | -0.003 |
| Enterprise Value | 21.53M |
| Earnings Yield | -3.43% |
| Normalized Earnings Yield | -3.431 |